240 related articles for article (PubMed ID: 28250277)
1. Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3.
Alfuwaires M; Altaher A; Kandeel M
Biol Pharm Bull; 2017; 40(3):345-351. PubMed ID: 28250277
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
3. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
[TBL] [Abstract][Full Text] [Related]
4. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
[TBL] [Abstract][Full Text] [Related]
5. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin.
Lei J; Hilgenfeld R
Virol Sin; 2016 Aug; 31(4):288-99. PubMed ID: 27245450
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
Bailey-Elkin BA; Knaap RC; Johnson GG; Dalebout TJ; Ninaber DK; van Kasteren PB; Bredenbeek PJ; Snijder EJ; Kikkert M; Mark BL
J Biol Chem; 2014 Dec; 289(50):34667-82. PubMed ID: 25320088
[TBL] [Abstract][Full Text] [Related]
7. Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases.
Kandeel M; Altaher A
Biol Pharm Bull; 2017 Jul; 40(7):1086-1091. PubMed ID: 28420819
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection.
Comar CE; Goldstein SA; Li Y; Yount B; Baric RS; Weiss SR
mBio; 2019 Mar; 10(2):. PubMed ID: 30914508
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
11. Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease.
Clasman JR; Everett RK; Srinivasan K; Mesecar AD
Antiviral Res; 2020 Feb; 174():104661. PubMed ID: 31765674
[TBL] [Abstract][Full Text] [Related]
12. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
13. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
[TBL] [Abstract][Full Text] [Related]
14. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
[TBL] [Abstract][Full Text] [Related]
15. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.
Oudshoorn D; Rijs K; Limpens RWAL; Groen K; Koster AJ; Snijder EJ; Kikkert M; Bárcena M
mBio; 2017 Nov; 8(6):. PubMed ID: 29162711
[TBL] [Abstract][Full Text] [Related]
16. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
Shokri S; Mahmoudvand S; Taherkhani R; Farshadpour F
J Cell Physiol; 2019 Mar; 234(3):2143-2151. PubMed ID: 30146782
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
Hui DS; Memish ZA; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
